Axel Wester
Impact in
- Hepatology top 10%
- Liver Disease and Transplantation
- Liver Diseases and Immunity
-
- Liver Disease Diagnosis and Treatment
Papers in ⓘ
- Hepatology 18
- Liver Disease and Transplantation 14
- Liver Diseases and Immunity 6
-
- Venous Thromboembolism Diagnosis and Management 4
- Co-authors
- Hannes Hagström (26 shared papers)Ying Shang (15 shared papers)Linnea Widman (11 shared papers)Sasha Koul (8 shared papers)Pontus Andell (4 shared papers)Patrik Nasr (5 shared papers)Stergios Kechagias (2 shared papers)Anthony Matthews (1 shared paper)
- Journals
- Liver International (5 papers)Clinical Gastroenterology and Hepatology (5 papers)Journal of Hepatology (4 papers)Journal of the American Heart Association (3 papers)Hepatology Communications (2 papers)
- Partner nations
- SwedenUnited StatesDenmark
In The Last Decade
Axel Wester
35 papers receiving 378 citations
Hit Papers
Peers
Comparison fields: 5 of 53
- Hepatology 108
- Epidemiology 210
- Endocrinology, Diabetes and Metabolism 99
- Internal Medicine 17
- Cardiology and Cardiovascular Medicine 91
Countries citing papers authored by Axel Wester
This map shows the geographic impact of Axel Wester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Wester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Wester more than expected).
Fields of papers citing papers by Axel Wester
This network shows the impact of papers produced by Axel Wester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Wester. The network helps show where Axel Wester may publish in the future.
Co-authors
The 25 scholars most cited alongside Axel Wester, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes Hit paper breakdown → | 2024 | 36 |
| 2 | 2024 | 34 | |
| 3 | 2019 | 26 | |
| 4 | 2022 | 24 | |
| 5 | 2019 | 24 | |
| 6 | 2022 | 22 | |
| 7 | 2023 | 19 | |
| 8 | 2020 | 16 | |
| 9 | 2023 | 15 | |
| 10 | 2022 | 13 | |
| 11 | 2021 | 13 | |
| 12 | 2025 | 12 | |
| 13 | 2023 | 11 | |
| 14 | 2023 | 9 | |
| 15 | 2024 | 9 | |
| 16 | 2024 | 9 | |
| 17 | 2022 | 9 | |
| 18 | 2018 | 9 | |
| 19 | 2020 | 9 | |
| 20 | 2023 | 9 |
About Axel Wester
Axel Wester is a scholar working on Hepatology, Internal Medicine, Epidemiology, Surgery and Cardiology and Cardiovascular Medicine, having authored 37 papers that have together received 379 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (19 papers), Liver Disease and Transplantation (14 papers), Alcohol Consumption and Health Effects (6 papers), Liver Diseases and Immunity (6 papers), Pancreatitis Pathology and Treatment (5 papers), Diet, Metabolism, and Disease (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Acute Myocardial Infarction Research (4 papers). The work is most often cited by research in Hepatology (108 citations), Epidemiology (210 citations), Endocrinology, Diabetes and Metabolism (99 citations), Internal Medicine (17 citations) and Cardiology and Cardiovascular Medicine (91 citations). Axel Wester has collaborated with scholars based in Sweden, United States and Denmark. Frequent co-authors include Hannes Hagström, Ying Shang, Linnea Widman, Sasha Koul, Pontus Andell, Patrik Nasr, Stergios Kechagias, Anthony Matthews, Moman A. Mohammad and David Erlinge. Their work appears in journals such as Liver International, Clinical Gastroenterology and Hepatology, Journal of Hepatology, Journal of the American Heart Association and Hepatology Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.